When given during pregnancy, RhIG may cross the placenta and sensitize fetal D-positive RBCs.

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Hemolytic Disease of the Fetus and Newborn (retired 4/6/2020). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Hemolytic Disease of the Fetus and Newborn (retired 4/6/2020) (online CE course)

When given during pregnancy, RhIG may cross the placenta and sensitize fetal D-positive RBCs.

Select true or false